Platform
Consulting
Resources
Pricing
The Novartis Health Equity Initiative - Canada
Closed

The Novartis Health Equity Initiative

Support projects improving health equity in Canada
Last Update: February 3, 2026
Funding available
No Condition
Timeline
  • Closing date : June 16, 2025
Location
Canada

Overview

This funding supports Canadian projects that reduce health disparities and improve equitable access to healthcare, with total available funding of $500,000 CAD. Eligible activities focus on social and cultural inclusivity, health literacy and education, and addressing barriers faced by newly arrived immigrants.
/100
Opportunity Score
Moderate potential, but conditions must align.

At a glance

Funding available

Financing goals
  • Increase social or community impact
  • Develop strategic partnerships
  • Raise awareness or mobilize a population
Eligible Funding
  • No Condition
Timeline
  • Closing date : June 16, 2025

Eligible candidates

Eligible Industries
  • Health care and social assistance
Location
  • Canada
Legal structures
  • Non-profit
Annual revenue
  • All revenue ranges
Organisation size
  • All organization sizes
Audience
  • All groups
Non-profit candidates
Sector of operation
  • All industries
Target groups
  • All the groups
Revenue structures
  • All structures
Scope
  • All dimensions

Next steps

1
Determine your project
2
Validate your eligibility

Activities funded

  • Projects that improve social and cultural inclusivity in healthcare for underserved populations.
  • Health literacy and education initiatives that address lack of information and contradictory health advice.
  • Initiatives supporting newly arrived immigrants with culturally and linguistically appropriate health information and services.

Eligibility

Who is eligible?

  • Eligible organizations with projects focused on health equity in Canada

Eligible geographic areas

  • Canada

Processing and Agreement

  • Funding decisions will be confirmed by October 2025.

Additional information

  • Total available funding is $500,000 CAD.
  • Funding decisions will be confirmed by October 2025.
  • The published deadline date was June 16, 2025.

Frequently Asked Questions about the The Novartis Health Equity Initiative Program

Here are answers to the most common questions about the The Novartis Health Equity Initiative. This section explains what the program is, how much funding is available, eligibility requirements, application deadlines, and other important details to help you determine if this grant is right for your business.

What is the The Novartis Health Equity Initiative?

This funding supports Canadian projects that reduce health disparities and improve equitable access to healthcare, with total available funding of $500,000 CAD. Eligible activities focus on social and cultural inclusivity, health literacy and education, and addressing barriers faced by newly arrived immigrants.

Who is eligible for the The Novartis Health Equity Initiative program?

To be eligible for the The Novartis Health Equity Initiative program, you must: Eligible organization Health equity project Underserved populations

What expenses are eligible under The Novartis Health Equity Initiative?

Projects that improve social and cultural inclusivity in healthcare for underserved populations. Health literacy and education initiatives that address lack of information and contradictory health advice. Initiatives supporting newly arrived immigrants with culturally and linguistically appropriate health information and services.

Who can I contact for more information about the The Novartis Health Equity Initiative?

You can contact Novartis Pharmaceuticals Canada Inc..

Where is the The Novartis Health Equity Initiative available?

The The Novartis Health Equity Initiative program is available across Canada.

Is the The Novartis Health Equity Initiative a grant, loan, or tax credit?

The Novartis Health Equity Initiative is a Grant and Funding

Who are the financial supporters of the The Novartis Health Equity Initiative?

The Novartis Health Equity Initiative is funded by Novartis Pharmaceuticals Canada Inc.